REAL‐WORLD OUTCOMES AND MANAGEMENT PATTERNS OF ACUTE TOXICITY FOLLOWING BISPECIFIC ANTIBODY THERAPY FOR PATIENTS WITH B‐CELL LYMPHOMA—THE GELTAMO EXPERIENCE | Publicación